Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries

Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries

BACKGROUND: Few studies have examined oral anticancer treatment utilization patterns among Medicare beneficiaries. OBJECTIVE: To assess treatment utilization patterns of newly initiated oral anticancer agents across national samples of Medicare beneficiaries for 5 cancer types: chronic myeloid leuke...

Full description

Bibliographic Details
Main Authors: Brown, V.T (Author), Doshi, J.A (Author), Jahnke, J. (Author), Li, P. (Author), Manz, C.R (Author), Puckett, J.T (Author), Raman, S. (Author), Ward, M.A (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
abiraterone
Administration, Oral
aged
Aged
Aged, 80 and over
antineoplastic agent
Antineoplastic Agents
Article
axitinib
bosutinib
Carcinoma, Renal Cell
chronic myeloid leukemia
clinical practice
dasatinib
Databases, Factual
drug utilization
economics
enzalutamide
everolimus
factual database
female
Female
follow up
hospice
human
Humans
imatinib
kidney metastasis
lapatinib
lenalidomide
major clinical study
male
Male
medicare
Medicare
Medication Adherence
medication compliance
metastatic breast cancer
middle aged
Middle Aged
multiple myeloma
nilotinib
oral drug administration
patient compliance
pazopanib
pomalidomide
ponatinib
Practice Patterns, Physicians'
prescription
prostate cancer
renal cell carcinoma
Retrospective Studies
retrospective study
sorafenib
sunitinib
thalidomide
United States
very elderly
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items